MedPath

Studies into the mechanism of measles-associated immune suppression during an outbreak of measles in The Netherlands

Completed
Conditions
Measles (Rubeola)
10047438
Registration Number
NL-OMON38941
Lead Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
200
Inclusion Criteria

In order to be eligible to participate in this study, a subject must meet all of the following criteria:
- Aged 4-17 years old
- Unvaccinated against measles
- No known history of natural measles

Exclusion Criteria

- Chronic disease
- Immune suppression (due to medication or underlying disease)

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Main study parameters/endpoints: The study consists of two cohorts. In cohort A<br /><br>clinical specimens (a blood sample and swabs of the upper respiratory tract)<br /><br>will be collected from children with an acute MV infection, shortly before, at<br /><br>or after onset of rash. The main study parameter in this group will be the<br /><br>characterization of MV-infected lymphocytes in peripheral blood, in order to<br /><br>confirm that the virus predominantly infects memory T- and B-lymphocytes. In<br /><br>cohort B blood samples will be collected from children that have not yet been<br /><br>exposed to MV. A second blood sample will be collected two to three weeks after<br /><br>recovery from measles. The main study parameter in this group will be the<br /><br>quantification of pre-existing memory lymphocyte populations in peripheral<br /><br>blood, to test the hypothesis that these cell populations are decimated during<br /><br>measles.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>As a secondary objective, we will try to validate and translate observations<br /><br>from our animal model studies to natural measles virus infections in children.<br /><br>To this end, we will measure hematological, virological and immunological<br /><br>parameters in white blood cells, plasma and swabs of the upper respiratory<br /><br>tract.</p><br>
© Copyright 2025. All Rights Reserved by MedPath